Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic changes due to iatrogenic hypogonadism in patients with prostate cancer: orchiectomy vs. triptorelin
2013-002553-29Phase 4Completed
- Sponsor
- Jens Sønksen
- Start
- Jul 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of triptorelin in prostate cancer (PCa) (2 arms), sponsored by Jens Sønksen. Primary endpoint: Change in fasting blood glucose. Started Jul 2013; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2013-002553-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002553-29.